Tadalafil Versus Tamsulosin or Silodosin as Medical Expulsive Therapy for Distal Ureteral Stones: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Abstract
Objective: Medical expulsive therapy (MET) facilitates the passage of distal ureteric stones. Alpha-blockers are the standard MET strategy. However, there has been grow ing interest in using tadalafil, a Phosphodiesterase type 5 (PDE5) inhibitor, to facilitate ureteral stone passage. Therefore, a systematic review and meta-analysis comparing tadalafil versus tamsulosin or silodosin was conducted as MET options for patients with distal ureteral stones. Methods: PubMed, Embase, and Cochrane Library were systematically searched in September 2023 for randomized controlled trials (RCTs) comparing tadalafil with alpha-blockers (tamsulosin or silodosin) for distal ureteric stones. Outcomes included stone expulsion rate (SER), stone expulsion time (SET), colic episodes, analgesic use, and side effects. Review Manager 5.4.1 was used for statistical analysis, applying a ran dom-effects model. Results: Eleven RCTs were included with 1345 patients, 579 (43%) randomized to tadalafil. No significant differences were found between groups for SER (risk ratio [RR] 1.07; 95% CI 0.98-1.18; P = .14), SET (RR −0.68; 95% CI −1.75 to 0.38; P = .21), colic epi sodes, or analgesic use. Headaches were significantly less frequent with alpha-blockers (RR 1.50; 95% CI 1.09-2.04; P = .01), while abnormal ejaculation was significantly less frequent in the tadalafil group (RR 0.38; 95% CI 0.19-0.74; P = .005). Conclusion: Given the comparable efficacy in stone expulsion and the distinct side effect…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,345 participants or records.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.